The key finding of our study is that inhibition of caspase-2 by TRIM25 constitutes a so far unrecognized pathway, which may be relevant for the resistance of human colon carcinoma cells to chemotherapy-induced apoptosis. This evidence concerns the gene CASP2 and colon carcinoma.